Clinical trial
Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia
NCT00233545 · AB Foundation, Other · Completed
Key facts
| NCT number | NCT00233545 |
|---|---|
| Title | Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia |
| Official title | Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia |
| Lead sponsor | AB Foundation, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis |
| Intervention type | Drug |
| Interventions | miltefosine, antimony |
| Enrollment | 80 |
| Start date | Sep 1, 2005 |
| Completion | Sep 1, 2007 |
| First posted | Oct 6, 2005 |
| Last update posted | Jun 2, 2010 |
| Countries | Bolivia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: